In both T1D and RA, genome-wide association studies (GWAS) have revealed dominant effects of the major histocompatibility complex (MHC) region, whose polymorphisms affect MHC class II antigen presentation and recognition [5–7]. This evidence concerns the gene HLA-C and rheumatoid arthritis.